• Colorectal Cancer Info MAIN MENU
  • Screening & Prevention MAIN MENU
  • Patient & Family Support MAIN MENU
  • Get Involved MAIN MENU
  • Funding Research MAIN MENU
  • Our Mission MAIN MENU

Subscribe to the Newsletter

Release of More Current Clinical Trials Data Gives Patients Access to Better Information Faster

Today, we announced our breakthrough collaboration with online patient community Smart Patients on a free Clinical Trials Database and online community for patients with colorectal cancer. These tools use data from www.cancer.gov—made available today by the National Cancer Institute (NCI) as part of the Cancer Moonshot Summit hosted by Vice President Biden in Washington, DC. Smart Patients was selected by the NCI and the VP's office to receive early access to this new data in order to provide feedback and incorporate the data into the Smart Patients online patient community.

In his remarks to the Cancer Moonshot Summit, Vice President Biden stated, “The Moonshot cannot be achieved by one person, one organization, one discipline, or even one collective approach.” He added, “Solving the complexities of cancer will require the formation of new alliances to defy the bounds of innovation and accelerate the prevention, diagnosis, treatment, and — ultimately — a cure. It’s going to require millions of Americans speaking up and contributing what they’re able. That’s what the Cancer Moonshot Summit is all about.” 

With the release of their advanced Clinical Trials Database, which is now available at www.smartpatients.com/ten, the Colon Cancer Alliance and Smart Patients has immediately answered Vice President Biden’s challenge. This user-friendly clinical trial search engine, designed specifically for colorectal cancer, supports personalization based on the molecular characteristics of one’s cancer. This means patients can access the latest precision medicine trials. This free resource is also supported by the Smart Patients online community where patients can learn from each other’s questions and experiences related to clinical trials and all aspects of their care. “We are at the beginning of a remarkable time in cancer care,” Smart Patients CEO Roni Zeiger, MD said. “We have a growing number of promising therapies as well as powerful technology that allows patients and those who care for them to learn faster—and learn from each other.”

Colorectal cancer is the third most commonly diagnosed cancer in America. Colon cancer strikes both men and women equally and affects all races. About 130,000 Americans will be diagnosed with colon cancer this year alone and about 50,000 Americans die from colon cancer each year. “Patients and researchers have endorsed our clinical trials resource as a transformative tool for increasing clinical trial participation,” CEO of the Colon Cancer Alliance Michael Sapienza commented. “Easy access to clinical trials information and available patient navigation provides the hope that so many patients come to the Colon Cancer Alliance looking for. We are proud to be collaborating with Smart Patients and working to answer the President’s call to end cancer as we know it.”

Don’t forget, the Colon Cancer Alliance serves as a source of information about colon health. If you have additional questions about colon cancer screening or are in need of support, please contact our free Helpline at (877) 422-2030.

Categories:

Related reading